Literature DB >> 11268954

The impact of clinical types of disease manifestation on the risk of early postoperative recurrence in Crohn's disease.

B Hofer1, T Böttger, T Hernandez-Richter, J K Seifert, T Junginger.   

Abstract

BACKGROUND/AIMS: Surgery for Crohn's disease is frequently followed by symptomatic recurrence, which in up to 40% requires reoperation within 6 years. Whilst there is evidence that postoperative medical prophylaxis can be efficient, the results of clinical trials are inconsistent regarding the achieved benefit for the patient. Several parameters have been claimed to indicate an increased intrinsic risk of early surgical recurrence.
METHODOLOGY: Patient charts of 287 patients who had undergone abdominal surgery for Crohn's disease were reviewed. Mean follow-up was 4.4 years. Recurrence-free intervals were calculated by the Kaplan-Meier method. A uni- and multivariate analysis was conducted to assess the impact of possible indicators of the need of repeated surgery.
RESULTS: Patients with fistulizing type of symptoms, extraintestinal manifestations, corticosteroid treatment or male gender experienced significantly earlier reoperation. Recurrent disease, histologic evidence of inflamed resection margins, patient's age at the time of primary diagnosis and operation and the presence of epitheloid granulomas did not show significant influence on recurrence-free intervals.
CONCLUSIONS: We conclude that the natural course of disease after intestinal resection in patients with one or more of these risk factors tends towards earlier recurrence requiring surgical intervention. The risk factors identified in this trial may be useful for patient stratification for randomized trials on the efficacy of medical prophylaxis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11268954

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  18 in total

Review 1.  Predicting, treating and preventing postoperative recurrence of Crohn's disease: the state of the field.

Authors:  Anna M Borowiec; Richard N Fedorak
Journal:  Can J Gastroenterol       Date:  2011-03       Impact factor: 3.522

2.  Surgical predictors of recurrence of Crohn's disease after ileocolonic resection.

Authors:  Marco Scarpa; Cesare Ruffolo; Eugenia Bertin; Lino Polese; Teresa Filosa; Daniela Prando; Duilio Pagano; Lorenzo Norberto; Mauro Frego; Davide F D'Amico; Imerio Angriman
Journal:  Int J Colorectal Dis       Date:  2007-05-30       Impact factor: 2.571

3.  Early re-laparotomy for post-operative complications is a significant risk factor for recurrence after ileocaecal resection for Crohn's disease.

Authors:  Thilo Welsch; Ulf Hinz; Thorsten Löffler; Gregor Muth; Christian Herfarth; Jan Schmidt; Peter Kienle
Journal:  Int J Colorectal Dis       Date:  2007-03-28       Impact factor: 2.571

4.  Phenotype at diagnosis predicts recurrence rates in Crohn's disease.

Authors:  F L Wolters; M G Russel; J Sijbrandij; T Ambergen; S Odes; L Riis; E Langholz; P Politi; A Qasim; I Koutroubakis; E Tsianos; S Vermeire; J Freitas; G van Zeijl; O Hoie; T Bernklev; M Beltrami; D Rodriguez; R W Stockbrügger; B Moum
Journal:  Gut       Date:  2005-12-16       Impact factor: 23.059

Review 5.  Risk of postoperative recurrence and postoperative management of Crohn's disease.

Authors:  Antonino Spinelli; Matteo Sacchi; Gionata Fiorino; Silvio Danese; Marco Montorsi
Journal:  World J Gastroenterol       Date:  2011-07-21       Impact factor: 5.742

Review 6.  Factors affecting recurrence after surgery for Crohn's disease.

Authors:  Takayuki Yamamoto
Journal:  World J Gastroenterol       Date:  2005-07-14       Impact factor: 5.742

7.  Factors associated with operative recurrence early after resection for Crohn's disease.

Authors:  Wisam Khoury; Scott A Strong; Victor W Fazio; Ravi P Kiran
Journal:  J Gastrointest Surg       Date:  2011-05-28       Impact factor: 3.452

8.  Sex Differences in Experimentally Induced Colitis in Mice: a Role for Estrogens.

Authors:  Janka Bábíčková; Ľubomíra Tóthová; Eva Lengyelová; Anastázie Bartoňová; Július Hodosy; Roman Gardlík; Peter Celec
Journal:  Inflammation       Date:  2015-10       Impact factor: 4.092

9.  Comparison of the effectiveness of infliximab and adalimumab in preventing postoperative recurrence in patients with Crohn's disease: an open-label, pilot study.

Authors:  A Tursi; W Elisei; M Picchio; C Zampaletta; G Pelecca; R Faggiani; G Brandimarte
Journal:  Tech Coloproctol       Date:  2014-06-12       Impact factor: 3.781

10.  Predictors of endoscopic recurrence in resected patients with Crohn's disease in a long-term follow-up cohort: History of multiple previous resections and residual synchronous disease in the remnant intestine.

Authors:  Yusuf Erzin; Gürhan Şişman; İbrahim Hatemi; Bilgi Baca; İsmail Hamzaoglu; Ahmet Dirican; Uğur Korman; Aykut F Çelik
Journal:  Turk J Gastroenterol       Date:  2020-04       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.